Recently we have showed that CXCR4 antagonism significantly attenuated the induction of cardiac fibrosis, renal fibrosis and left ventricular hypertrophy in the DOCA model of mineralocorticoid excess [18]. The gene discussed is CXCR4; the disease is left ventricular hypertrophy.